Risk of malignancy in patients treated for systemic necrotising vasculitis.
Lafarge A, Joseph A, Pagnoux C, Puechal X, Cohen P, Samson M, Hamidou M, Karras A, Groh M, Quemeneur T, Ribi C, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG).
Lafarge A, et al. Among authors: cohen p.
Ann Rheum Dis. 2020 Mar;79(3):431-433. doi: 10.1136/annrheumdis-2019-216452. Epub 2019 Nov 25.
Ann Rheum Dis. 2020.
PMID: 31767700
No abstract available.